Omega-3 Polyunsaturated Fatty Acids and Stroke Burden

• Published in: International Journal of Molecular Sciences
• Main Authors: Ueno, Yuji, Miyamoto, Nobukazu, Yamashiro, Kazuo, Tanaka, Ryota, Hattori, Nobutaka
• Format: Text
• Language: English
• Published: MDPI 2019
• Subjects: Review; Greenland; eskimo*
• Online Access: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6888676/; http://www.ncbi.nlm.nih.gov/pubmed/31703271; https://doi.org/10.3390/ijms20225549

Stroke is a major leading cause of death and disability worldwide. N-3 polyunsaturated fatty acids (PUFAs) including eicosapentaenoic acid and docosahexaenoic acid have potent anti-inflammatory effects, reduce platelet aggregation, and regress atherosclerotic plaques. Since the discovery that the Greenland Eskimo population, whose diet is high in marine n-3 PUFAs, have a lower incidence of coronary heart disease than Western populations, numerous epidemiological studies to explore the associations of dietary intakes of fish and n-3 PUFAs with cardiovascular diseases, and large-scale clinical trials to identify the benefits of treatment with n-3 PUFAs have been conducted. In most of these studies the incidence and mortality of stroke were also evaluated mainly as secondary endpoints. Thus, a systematic literature review regarding the association of dietary intake of n-3 PUFAs with stroke in the epidemiological studies and the treatment effects of n-3 PUFAs in the clinical trials was conducted. Moreover, recent experimental studies were also reviewed to explore the molecular mechanisms of the neuroprotective effects of n-3 PUFAs after stroke.